This innovation, developed after four and a half years of workallows physicians totailor patient treatment more effectively. The idea of ​​this online platform and the use of artificial intelligence came from doctor Alexandre Loupy, who found that misdiagnoses were common, reaching about 40% of casesdue to complexity of the Banff classification used for diagnose transplant rejection. Through this interface, patient data can be entered quickly to obtain a diagnosis in less than a second.

This French medical technology represents a revolution, offering both technological and medical advantages, thus allowing toadjust treatment based on results. The tool has already been tested on 3,000 patients at the Saint-Louis hospital in Pariswhere the doctor Gillian Divard points out that he does not replace the doctor, but that he is extremely useful for confirm an accurate diagnosis and guide the choice of treatment. This innovation ensures a greater safety for patientsbecause undiagnosed rejection increases the risk of graft loss, which can have catastrophic consequences on their quality of life and life expectancy (source 1). The promising results of the experiment carried out on 3,000 patients have proven the effectiveness of this IT tool, which will soon be used worldwide to improve patient care.